Please login to the form below
rheumatology
This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.
US ‘unicorn’ Samumed on track with lead arthritis drug
The San Diego company presented data at this week’s American College of Rheumatology (ACR) meeting showing that a single injection of SM04690 into the joints of people with OA of
Latest news
-
Gilead and Galapagos JAK contender scores in RA trial
The FINCH 2 trial of filgotinib in adults with moderately-to-severely active rheumatoid arthritis achieved its primary endpoint in the proportion of patients achieving an American College of Rheumatology 20%
-
Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS
Rheumatology congress EULAR convenes in Amsterdam (pictured) from Wednesday, with data being presented across a range of inflammatory disorders. One category to watch is the JAK inhibitors, including AbbVie’s phase
-
Novartis’ Cosentyx takes on Humira and biosimilar in phase III showdown
The EXCEED and SURPASS head-to-head trials are addressing important clinical questions solving residual uncertainty for patients with PsA and AS," commented Dr Robert Landewé, professor of Rheumatology in the ... Amsterdam Rheumatology and Clinical
-
Boehringer builds evidence base for its Humira biosimilar
However, Boehringer will still push on with presenting its new data at the forthcoming Association of Rheumatology Health Professionals annual meeting in California, US.
-
EU’s 10-year paediatric meds report - not bad, but can do better
The bulk of paediatric investigation plans (PIPs) completed during the period have been in immunology/rheumatology (14%), infectious diseases (14%), cardiovascular diseases and vaccines (10% apiece), says the report, but cancer
More from news
Approximately 1 fully matching, plus 68 partially matching documents found.
Latest Intelligence
-
Case study: Immunology education
There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic (Manchester Royal
-
Pharma deals during April 2014
proteinuria associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms. Whilst this is a 60-year old drug acquired by Questcor in 2001 for $100, 000, generic competition is
-
Pharma deals during February 2014
in litigation over two synthetic versions of Acthar (ACTH), a corticotropin with 19 indications, many in rare diseases including infantile spasms, MS, nephrology, and rheumatology.
-
Interview: Pierre Chancel, Sanofi Diabetes
Marketing Director Theraplix, Rhône-Poulenc. Business Unit Manager for CNS, Rheumatology and HRT, Rhône-Poulenc.
-
Interview: Deepak Khanna, ABPI
In 1996, Deepak joined the Worldwide Human Health Marketing Division working with rheumatology products; he later assumed responsibility for the marketing planning activities to support early stage central nervous system products.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Amgen appoints senior VP and head of the European region
Merck Serono, where she was senior VP of strategy and global marketing for neurology, rheumatology and immunology.
-
Bone Therapeutics looks to Pfizer for clinical head
Heynen is a specialist in rheumatology and immunology, with over 35 years of experience in medical and regulatory affairs at local, regional and international levels.
-
Aurora expands its team with three new hires
Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and
-
Genentech’s Sunil Agarwal joins rare disease firm
He spent just over 10 years at Genentech where his positions included senior VP for immunology and infectious diseases and VP for rheumatology.
-
Voltarra names new CEO
In his new role, he leads a company with a pipeline of drugs for rheumatology, central nervous system oncology and immunology.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK
Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.
-
Bringing the NHS into the 21st century
We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.
-
Healthcircle
Rx &Medical Devices. Oncology. Haematology. Rheumatology. Anti-infectives. Anti-virals. Cardiovascular. Respiratory. Endocrinology.
-
IGNIFI
Our diverse experience in human and animal health includes:. gastroenterology . rheumatology .
-
The Biosimilar Challenge
In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of biosimilars across a range of therapy areas – especially in rheumatology. ... The pressure is now on to undertake the same in rheumatology, dermatology and
More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Systematic Reviewer - Oxford
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Account Director
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Business Development Director – Health Education
-
excellent commission
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Medical Writer
-
Salary TBC
- Account Manager- Healthcare Advertising
-
Negotiable
-
Senior Account Manager
-
Competitive Salary Offered
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
-
Account Manager
-
Negotiable
Subscribe to our email news alerts
- Is China ready for a pharmaceutical gold rush?
- We've moved!
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- Dragonfly signs Celgene as partner for NK cell platform
- NICE appraisal fees to be introduced despite opposition
- AZ still sees route to approval for Imfinzi in MYSTIC trial
PMHub
Hive
We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...
Latest intelligence
- Is China ready for a pharmaceutical gold rush?
- Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Quick links
Infographics
